Verition Fund Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Verition Fund Management's GH Position: Q2 2026 in Review
Verition Fund Management increased its Guardant Health (GH) stake by 13% in Q2 2026, buying an estimated $309K and bringing the position to 24,049 shares worth $3.61M. The position accounts for 0.02% of the portfolio, ranked #815.
Verition Fund Management first reported a position in GH in Q3 2020 and has held it in 17 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Verition Fund Management held 24,049 shares of Guardant Health worth $3.61M as of Q2 2026.
- Verition Fund Management bought 2,839 Guardant Health shares in Q2 2026, an estimated $309K.
- Guardant Health made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #815 holding.
- Verition Fund Management first reported a position in Guardant Health in Q3 2020 and has held it in 17 quarters since.
- 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.